Menard Financial Group LLC Bristol Myers Squibb CO Transaction History

Menard Financial Group LLC

  • $146 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $142,293 - $159,106
2,458 Added 75.65%
5,707 $331,000
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $206,993 - $229,834
3,249 New
3,249 $207,000
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $267,482 - $316,737
3,906 New
3,906 $280,000

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email